Unlock a broad range of applications with one powerful instrument
Kits & Reagents
Improved Q30 score, support for UMIs, extended shelf life, and support for Illumina DNA PCR-Free Library Prep
Selection & Planning Tools
Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price
Software & Informatics Products
DRAGEN v3.10 release now available, setting new standards for accuracy and increased genome coverage.
Fast, high-quality, sample-to-data next-generation sequencing services
See what is possible through the latest advances in high-throughput sequencing technology
Empower the next generation of scientists and engineers through educational opportunities and resources
All Investor Information
All Legal Information
Manage the security and set up networking for your sequencing system
All Support Tools
Product Support Services
Solutions to enable comprehensive genomic profiling, from tissue to liquid biopsy samples
Cancer Research Products
Microbial Genomics Research
Monitor SARS-CoV-2 variants and other respiratory viruses in the community
Microbial Genomics Products
A collaboratively designed universal genotyping platform can keeping costs reasonable and provide optimal outcomes
Complex Disease Research Products
Sequencing with the VeriSeq NIPT Solution v2 enables comprehensive insights reducing the need for invasive tests
Reproductive Health Products
Technology innovation and collaboration in health care to ensure families receive a diagnosis early
Genetic Health Products
Four complementary RNA-Seq methods using hundreds of cell types and tissues produced the most comprehensive atlas of the human transcriptome to date.
Sequencing quality is not uniform across the genome and impacts somatic variants calling. Here we quantify the performance gap between high-and low-quality regions.
Illumina researchers developed a robust workflow for sequencing RNA in the blood, obtaining a noninvasive snapshot of whole-body health with the potential of transforming the future of diagnostics.